Search clinical trials for: T-cell vaccine

Total 11417 results

Solvay Pharmaceuticals

Withdrawn

Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Healthy Volunteers

Germany
Pevion Biotech Ltd

Completed

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Chronic Hepatitis C

Switzerland
UMN Pharma Inc.

Completed

Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults

Virus Diseases | Influenza

Japan
Shantha Biotechnics Limited
PATH

Withdrawn

Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants

Rotavirus Infections

India
TD Vaccines A/S
Johns Hopkins University; Pierrel Research USA, Inc.

Completed

ACE527 Safety and Immunogenicity Study

Enterotoxigenic E. Coli (ETEC) Infection

United States
Shanghai Public Health Clinical Center
Beijing Ditan Hospital; National Institute for the Control of Pharmaceutical...

Unknown

Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Influenza | Orthomyxoviridae Infections

China
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Precancerous/Nonmalignant Condition

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Pneumococcal Infections
Cancer Institute and Hospital, Chinese Academy...
Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control; National Institute for the Control of Pharmaceutical and Biological Products, China

Completed

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)

Poliomyelitis

China
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine

Dengue

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma

Multiple Myeloma

United States
Protein Sciences Corporation

Completed

Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults

Influenza

United States
National Taiwan University Hospital

Unknown

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

Serology Analysis | Novel H1N1 Influenza Vaccination | Pediatric Haemato-oncology Patients

Taiwan
Universidade Cidade de Sao Paulo

Completed

Knowledge and Attitude About HPV Vaccines

Behavior | Attitude | Knowledge

Brazil
Centers for Disease Control and Prevention, China

Unknown

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month

Influenza | Swine-origin A/H1N1 Influenza

China
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Terminated

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer

Breast Cancer

Japan
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Terminated

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

Colorectal Cancer | Rectal Cancer | Colon Cancer

Japan
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Terminated

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer

Breast Cancer

Japan
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Terminated

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

Colorectal Cancer | Rectal Cancer | Colon Cancer

Japan
Hadassah Medical Organization

Unknown

Assessment of Safety and Immunogenicity of Intradermal Unadjuvanted Portion of Pandemrix® Via a Microneedle Device With Intramuscular Adjuvanted Pandemrix® as Reference

Healthy

Israel
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Cytomegalovirus Vaccine in Healthy Participants

Precancerous/Nonmalignant Condition

United States
St. Antonius Hospital

Completed

Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy (RIFLUVAC)

Heart Failure | Mamma Carcinoma

Netherlands
Protein Sciences Corporation

Completed

Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics

Influenza

United States
Protein Sciences Corporation

Completed

Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults

Influenza

United States
Swiss Tropical & Public Health Institute
Radboud University Medical Center; Centre Hospitalier Universitaire Vaudois

Completed

Trial to Assess the Efficacy of Malaria Vaccine PfCS 102 (DG002)

Plasmodium Falciparum Malaria

Switzerland
University of Medicine and Dentistry of New Jersey
Ortho Biotech, Inc.

Terminated

LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma

T-Cell Lymphoma

United States
AVIR Green Hills Biotechnology AG

Completed

Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers (GHBCS-01)

Seasonal Human Influenza

Austria
International Vaccine Institute
National Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics...

Completed

Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine

Diarrhea | Cholera | Vibrio Infections

India
Cytos Biotechnology AG

Completed

Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension

Hypertension

Switzerland, Germany
University Hospital, Basel, Switzerland

Completed

Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma

Melanoma

Switzerland
Cancer Institute and Hospital, Chinese Academy...

Unknown

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

Cervical Cancer | HPV Infections | Precancerous Disease of the Cervix | HPV Related Diseases
French National Agency for Research on AIDS and...
EuroVacc Foundation

Completed

Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers (EV03/ANRSVAC20)

HIV Infections

France, Switzerland
Objectif Recherche Vaccins SIDA

Completed

Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients (MANON 02)

HIV Infection

United States, France, Germany, Spain
Objectif Recherche Vaccins SIDA

Completed

Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route (MANON-05)

HIV Infection | Healthy Volunteers

Germany
LG Life Sciences

Completed

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

Infectious Disease by Haemophilus Influenzae Type b

Korea, Republic of
Tel-Aviv Sourasky Medical Center

Unknown

Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Inflammatory Bowel Diseases (IBD) Treated Immunomodulators and Biologics

Influenza H1N1
Goethe University
HIVCENTER

Unknown

Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

Cancer | Immunosuppression | HIV-1 Infection

Germany
Eli Lilly and Company

Completed

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Major Depressive Disorder

United States, Puerto Rico
Henogen

Completed

Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™

Hepatitis B

Belgium, Czech Republic, Hungary
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

Gastric Cancer

Japan
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

Esophageal Cancer

Japan
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

Esophageal Cancer

Japan
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

Gastric Cancer

Japan
Tehran University of Medical Sciences
Pasteur Institute of Iran, Tehran, Iran; Razi Vaccine and Serum Research Institute and other collaborators

Completed

Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)

Healthy

Iran, Islamic Republic of
Hospital Universitari Son Dureta
Fondo de Investigacion Sanitaria; Hospital Son Llatzer

Unknown

Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults

HIV Infections | HIV | Pneumococcal Vaccines

Spain
Novartis
Novartis Vaccines

Completed

Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine

Influenza Infection

Switzerland
Tel-Aviv Sourasky Medical Center

Unknown

Vaccination Against Influenza H1N1 in Rheumatic Diseases

Rheumatic Diseases | Influenza
Tel-Aviv Sourasky Medical Center

Unknown

Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Israel
Tel-Aviv Sourasky Medical Center

Unknown

Influenza Vaccination in Patients With Scleroderma

Influenza Vaccine in Scleroderma

Israel
University of British Columbia

Withdrawn

Rapid Evaluation of Seasonal Influenza Vaccine

Influenza

Canada

Search clinical trials for: T-cell vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations